U.S. Surgical Dressings Market Size, Share & Trends Analysis Report By Product (Primary, Secondary), By Application (Ulcers, Burns, Diabetes Related Surgeries, Cardiovascular Related Surgeries), By End Use (Hospitals, Specialty Clinics), And Segment Forecasts, 2025 - 2030

U.S. Surgical Dressings Market Trends

The U.S. surgical dressings market size was estimated at USD 1.52 billion in 2024 and is expected to grow at a CAGR of 4.09% from 2025 to 2030. The rising number of surgical procedures and the growing prevalence of chronic wounds, such as diabetic foot ulcers & pressure ulcers, are some of the factors driving the market growth. According to data published by the Agency for Healthcare Research and Quality in February 2024, approximately 2.5 million people develop pressure ulcers in the U.S. Furthermore, innovations like smart dressings and 3D printing are anticipated to boost the effectiveness of surgical dressings.

Moreover, the increasing prevalence of organ transplant surgeries significantly drives the surgical dressings market due to the heightened demand for specialized wound care products post-surgery. For instance, as per a report by the Organ Procurement and Transplantation Network, in January 2025, around 48,149 transplants were performed in the U.S., marking a 3.3 percent increase compared to the total in 2023 and a 23.3 percent rise over the past five years in the U.S. As organ transplant surgeries rise, the need for advanced wound care solutions such as antibacterial dressings, hydrocolloids, hydrogels, and film dressings is anticipated to increase. These dressings offer optimal moisture balance, enhance healing, and provide antimicrobial properties, essential for patients recovering from invasive surgeries like organ transplants.

The growing prevalence of chronic and acute wounds, including diabetic ulcers, pressure ulcers, burns, and venous leg ulcers, is the key factor driving the growth of the U.S. surgical dressings market. This rise is mainly due to the increasing incidence of chronic diseases such as diabetes, cardiovascular conditions, and cancer. According to CDC data published in December 2023, around 96 million adults (38% of U.S. adults) have prediabetes, with over 80% unaware of their condition. Diabetic foot ulcers are a common complication of severe diabetes, while pressure ulcers often occur in cancer patients.

Source: IARC, Grand View Research Analysis

Therefore, the high burden of these chronic diseases is expected to boost the demand for surgical dressings to manage wounds arising from surgical procedures related to these conditions.

In addition, there has been a significant rise in cosmetic surgical procedures. Data released by Discovery ABA in February 2024 reveals that roughly 26.2 million surgical and minimally invasive reconstructive and cosmetic procedures were performed in 2022 in the U.S., reflecting a significant 19% increase in cosmetic surgeries since 2019. Surgical dressings are utilized during aesthetic and plastic surgeries. Thus, the growing number of cosmetic surgical procedures is projected to further enhance market growth over the forecast period. 

Market Concentration & Characteristics

The market growth stage is moderate, and the pace is accelerating. The U.S. surgical dressing market is characterized by a moderate degree of growth owing to the rising prevalence of chronic diseases, increasing number of organ transplantation procedures, growing geriatric population base, rising number of surgeries, and technological advancements in surgical dressings.

The degree of innovation is high as market players focus on developing novel dressings incorporating advanced technology to enhance their product offerings and improve their products. For instance, in January 2024, Medline introduced a new product to its line of advanced wound care solutions, the OptiView Transparent Dressing with HydroCore Technology. This innovative wound dressing is transparent, enabling caregivers to conveniently inspect, monitor, and assess skin blanching while the dressing remains in place.

The market is experiencing high levels of mergers and acquisitions, as established players are acquiring emerging companies to enhance their market presence and expand their offerings. For instance, in March 2022, Convatec Group PLC, a player offering surgical wound dressings, purchased Triad Life Sciences, Inc. to enter the wound biologics segment. Triad’s team, current portfolio, and product pipeline were transitioned to Convatec’s Advanced Surgical Dressing (AWC) business.

Regulatory bodies play a crucial role in classifying surgical dressings to ensure proper use and better outcomes. The U.S. Food and Drug Administration (FDA) regulatory authority oversees the clinical trials, approvals, and marketing authorization of surgical dressings in the U.S. For instance, in April 2023, 3M announced the U.S. FDA approval for 3M Veraflo Therapy dressings intended for hydromechanical removal of nonviable tissue.

The U.S. surgical dressings market is fragmented, with various players vying for market share. Several small, medium, and large companies operate in the market. Some of the established companies in the market include 3M, Smith+ Nephew, Mölnlycke Health Care AB, ConvaTec Group PLC, and Medline Industries, Inc., among others.

Product Insights

The primary dressing segment dominated the market, accounting for 42.90% of the revenue in 2024 due to the advancements in materials foam, hydrocolloid, and film dressings aimed at faster healing and reducing the risk of infection. Moreover, products such as hydrogel and alginate dressings are gaining popularity due to moisture-retentive properties and biodegradable options to enhance patient safety and environmental sustainability. Furthermore, studies are demonstrating positive outcomes for primary dressings. For instance, the study published by MJH LiveScience in October 2022 showed silver hydrogel dressings demonstrated substantial improvement in patients with postoperative scars and burns. Such positive results are anticipated to boost the segment demand over the forecast period.

The other segment is expected to grow fastest CAGR over the forecast period. Other surgical dressings encompass a variety of materials and products used to support primary dressings and enhance the healing process. These dressings are typically used to secure, protect, and absorb additional exudate from wounds, providing an extra layer of protection to prevent infection and promote faster recovery.

Application Insights

The other application segment dominated the market in 2024. The other segments include brain surgeries, accident-related surgeries, and gastrointestinal (GI) surgeries. Each of these procedures requires specialized wound care due to the unique nature of the surgeries and the potential for complications. A growing number of road accidents and sports injuries are anticipated to drive the segment growth over the forecast period. The National Safety Council reports that sports and recreational injuries increased by 20% in 2021, 12% in 2022, and 2 % in 2023.

The cardiovascular-related surgeries segment is expected to witness significant growth during the forecast period, driven by the high number of surgeries related to heart conditions, such as coronary artery bypass grafting (CABG) and valve replacements. According to the data published by Baystate Health in February 2024, almost 400,000 CABG surgeries are performed in the U.S. Patients undergoing these procedures often face complex wound care challenges due to the nature of the surgeries and the potential for infection, delayed healing, or complications. As such, specialized surgical dressings are essential for managing these wounds. Advanced dressings, including antimicrobial, hydrocolloid, and foam-based materials, help reduce the risk of infection, manage exudate, and promote faster healing, which is particularly important for patients with CVDs, as their ability to heal can be compromised. 

End Use Insights

The hospitals segment dominated the market and accounted for the largest revenue share, at 53.98% in 2024. Hospitals often adopt advanced wound care technologies and treatments to optimize patient outcomes. This includes specialized dressings, advanced devices, and innovative therapies. In addition, hospitals encounter a high patient pool with several chronic conditions, such as diabetes, peripheral vascular diseases, and pressure injuries, necessitating comprehensive wound care services. In addition, the growing number of hospitals nationwide is anticipated to boost the demand for surgical dressings in the U.S. market. According to the data published by the American Hospital Association, there are 6,093 hospitals in the U.S.

The ambulatory surgery centers segment is expected to grow with the highest CAGR during the forecast period, owing to the increasing number of patients visiting ambulatory surgery centers. In addition, the growing number of ASCs and rising number of surgeries being performed in these settings due to various benefits such as cost-effectiveness, shorter stay time, and support from government bodies is anticipated to support the segment growth. In 2022, approximately 6,100 ASCs treated 3.3 million fee-for-service Medicare beneficiaries. Thus, with an increase in the number of ASCs and the number of surgeries being performed, demand for wound care products is expected to increase.

Inpatient Reimbursement Summary And Physician Fee Schedule for Procedures Utilizing Integra Wound Matrix - 2025

Source: CMS, Company Websites, Grand View Research Analysis

In the U.S., the availability of reimbursement for surgical dressings, particularly for burn procedures such as Integra Wound Matrix, plays a crucial role in driving market growth. Establishing specific MS-DRG codes and Medicare National Average Payment Rates for these procedures reduces financial barriers for healthcare providers, encouraging the adoption of advanced wound care products. This supportive reimbursement landscape enhances market access, promotes the use of high-quality dressings like Integra Wound Matrix, and boosts demand, contributing to the overall growth of the U.S. surgical dressings market.

Key U.S. Surgical Dressings Market Company Insights

Smith+Nephew, Mölnlycke Health Care AB, Convatec Group PLC, Essity, DeRoyal Industries, Inc., Coloplast Corp, 3M, INTEGRA LIFESCIENCES, Medline Industries, LP, Cardinal Health,  MIMEDX Group, Inc., and Urgo Medical North America are some major players in the U.S. surgical dressing industry. Industry players are engaging in various strategic initiatives, including acquisitions, partnerships, and collaborations. Moreover, launching novel products is anticipated to boost the competitive rivalry in the U.S. surgical dressings industry. 

Recent Developments

• In March 2024, Integra LifeSciences Corporation launched MicroMatrix Flex in the US market. This innovative dual-syringe system facilitates the easy blending and accurate application of MicroMatrix paste in inaccessible areas, aiding in the creation of a uniform wound surface in difficult-to-treat wound sites.

• In January 2024, Medline introduced a new product to its line of advanced wound care solutions, the OptiView Transparent Dressing with HydroCore Technology. This innovative wound dressing is designed with a clear material, enabling caregivers to conveniently inspect, monitor, and assess skin blanching while the dressing remains in place.

• In January 2024, 3M Health Care’s Medical Solutions Division has been granted a USD 34.2 million award aimed at enhancing the management of traumatic wounds from the moment of injury to the hospital and advancing the healing process in the U.S.

U.S. Surgical Dressings Market Report Scope

U.S. Surgical Dressings Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. surgical dressings market report based on product, application, and end use:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Primary

    • Foam Dressing

    • Alginate Dressing

    • Soft Silicone Dressing

    • Composite Dressing

    • Hydrogel Dressing

    • Hydrocolloid Dressing

    • Film Dressing

  • Secondary

    • Absorbents

    • Bandages

      • Muslin Bandage Rolls

      • Elastic Bandage Rolls

      • Triangular Bandages

      • Orthopedic Bandages

      • Elastic Plaster Bandages

      • Other Bandages

    • Adhesive Tapes

    • Protectives

    • Others

  • Others

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Diabetes related surgeries

  • Cardiovascular related surgeries

  • Ulcers

  • Burns

  • Transplant Sites

  • Others

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Specialty Clinics

  • Home Healthcare

  • Ambulatory Surgery Centers

  • Others